Peak Spirit/CMC strategy for early-stage Biotech / Pharma companies

CMC strategy for early-stage Biotech / Pharma companies

Starts on Sep 25 at 12PM CET

Viopas Venture Consulting

This webinar is cohosted by Viopas Venture Consulting

Viopas is our partner, focusing on biotech and pharma. Their expertise has been key in creating the Biotech Courses at this Academy.

Check out their website, LinkedIn, & the Biotech Courses.

This session covers Healthtech & Biotech

Session held by: Sven Beichler

Co-founder & CEO at TOM Medications, Angel Investor & Entrepreneur for more than 20 years.

Rudolf is a senior expert in chemistry, manufacturing and controls (CMC) technical development and production from API to finished product and technical operations with additional experience in clinical and commercial supply chain management and quality assurance. He has broad expertise in CMC areas of small molecules, biologics and peptides accumulated over 25 years in leadership positions the pharmaceutical industry in Big Pharma and emerging Pharma/Biotech companies.

Mail - LinkedIn - Website

Interested in learning more?

This Expert Session is only available for selected participants. If you don't have access and would like to participate, reach out to Peak Spirit any time:

Not able to join?

No problem! We record all expert sessions and make them available for the startups - including the slides!